Improved methodologies to measure novel alcohol biomarkers in whole blood
Improved methodologies to measure novel alcohol biomarkers in whole blood
批准号:
8183977
负责人:
KUMAR SUBRAMANIAN
金额:
$21.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2015-02-28
关键词:
AffectAgeAlcohol abuseAlcohol consumptionAlcoholsBiologicalBiological AssayBiological MarkersBloodBody mass indexClinicalDetectionEnzyme TestsEnzyme-Linked Immunosorbent AssayEthanolFoundationsGamma-glutamyl transferaseGenderGoalsHalf-LifeHigh Pressure Liquid ChromatographyIntakeLiverMeasurableMeasuresMetabolicMethodologyMethodsOrganPatientsPhasePhospholipasePhospholipase DPhospholipidsPhysiciansPropertyRecording of previous eventsResearchResearch PersonnelSamplingSpecificityStandardizationTestingTissuesValidationWhole BloodWorkalcohol use disorderbasecarbohydrate-deficient transferrinimprovedmean corpuscular volume observednovelphosphatidylethanolproblem drinkerresponsesobrietytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Phosphatidylethanol (PEth) is a phospholipid formed only in the presence of ethanol via the action of phospholipase D. It has been measured in whole blood and proposed as a marker of ethanol abuse due to its high specificity and low degradation rate. The mean half-life of PEth in blood from alcoholics was found to be 4 days, and PEth was still measurable after 2 weeks of sobriety. Our overall goal is to expand on our successful preliminary work and develop a sensitive, high throughput ELISA biomarker assay for PEth analysis in whole blood. Current methods of analysis of PEth are based on the high performance liquid chromatography-mass spectrometric methods. Unavailability of rapid assays for the detection and the lack of standardization of the tests have hampered the clinical use of these biomarkers. The final PEth ELISA product that would result from this application could have a significant impact in the study and management of alcohol use disorders.
PUBLIC HEALTH RELEVANCE: Our overall goal is to expand on our successful preliminary work and develop a sensitive, high throughput ELISA biomarker assay for PEth analysis in whole blood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID POINT OF CARE DIAGNOSTICS FOR HCV
-
批准号:10497110
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Low cost, automated smartphone based assay for semen analysis
-
批准号:10028296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Multiplexed Point Of Care Nucleic Acid Assay for STI
-
批准号:9074908
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2016
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
IGF::OT::IGFTitle: Multiplexed Biosensor for Detecting Low Abundance Cancer-rel
-
批准号:8761949
-
项目类别:
-
资助金额:$99.98万
-
财政年份:2013
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
RAPID AND SENSITIVE IDENTIFICATION OF HIV ANTIGEN AT THE POINT OF USE
-
批准号:8603499
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2013
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
High throughput Point-of-Care assays for diabetes auto-antibody detection
-
批准号:8402736
-
项目类别:
-
资助金额:$28.05万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
POINT OF CARE DIAGNOSTICS FOR URINARY TRACT INFECTION
-
批准号:8394577
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Multiplexed Biomarkers for staging Alzheimer???s Disease
-
批准号:8371247
-
项目类别:
-
资助金额:$17.08万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
High throughput Point-of-Care assays for diabetes auto-antibody detection
-
批准号:8546380
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2012
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MULTIPLEXED BIOSENSOR FOR DETECTING LOW ABUNDANCE CANCER
-
批准号:8356444
-
项目类别:
-
资助金额:$19.65万
-
财政年份:2011
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Home-Based Lithium Level Testing for Bipolar Patients
-
批准号:7922943
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Low-Cost, Onsite Biomarker Test Kits for Alcohol-Associated Disorders (Phoenix)
-
批准号:7947218
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
BIOMEDICAL (APPLIED/EXPLORATORY)
-
批准号:8039750
-
项目类别:
-
资助金额:$14.56万
-
财政年份:2009
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Real Time Monitoring of Environmental Exposure To Pesticides
-
批准号:7497426
-
项目类别:
-
资助金额:$29.72万
-
财政年份:2007
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Real Time Monitoring of Environmental Exposure To Pesticides
-
批准号:7362895
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2007
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Sternal Skin Conductance Monitoring
-
批准号:7012102
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2005
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
Nanoliter Glucose Assay For Diabetics
-
批准号:6643891
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2003
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:6589580
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:7414517
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
MEMS Based Continuous Alcohol Monitoring Device
-
批准号:7234717
-
项目类别:
-
资助金额:$40.72万
-
财政年份:2002
-
负责人:KUMAR SUBRAMANIAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: